MolNFT v1 · #163640 · protein + RNA
Cryo-EM structure of the type III-B cmr-beta bound to cognate target RNA and amppnp, state 2
6S91 · CRISPR-associated protein, CMR5 family: “Cryo-EM structure of the type III-B cmr-beta bound to cognate target RNA and amppnp, state 2”. Electron microscopy, 3 ligands (ANP, MN, ZN), 20 pockets (best druggability 0.89). MolNFT v1…
- PDB
- 6S91
- Type
- protein + RNA
- Length
- 7,572 residues
- Chains
- 35
- Method
- electron microscopy
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- CRISPR-associated protein, CMR5 family; CRISPR-associated ramp protein, CMR4 family…
- UniProt
- F0NDX5, F0NDX6, F0NDX1, F0NDX3, F0NDX4, F0NDX2, F0NDX7
- Ligands
- ANP, MN, ZN
- Pockets
- 20 · best druggability 0.89
Structure
electron microscopy · 12 distinct chains · 38% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | CRISPR-associated protein, CMR5 family | protein | 153 | 76% helix, 0% strand | F0NDX5 |
| B | CRISPR-associated protein, CMR5 family | protein | 151 | 60% helix, 0% strand | F0NDX5 |
| C | CRISPR-associated protein, CMR5 family | protein | 154 | 74% helix, 0% strand | F0NDX5 |
| D, E, F | CRISPR-associated ramp protein, CMR4 family | protein | 285 | 27% helix, 31% strand | F0NDX6 |
| G | CRISPR-associated ramp protein, CMR4 family | protein | 283 | 24% helix, 31% strand | F0NDX6 |
| H | CRISPR-associated protein, CMR3 family | protein | 312 | 21% helix, 32% strand | F0NDX1 |
| I | CRISPR-associated ramp protein, CMR6 family | protein | 284 | 40% helix, 18% strand | F0NDX3 |
| J | CMR1,CRISPR-associated ramp protein, CMR1 family | protein | 467 | 33% helix, 20% strand | F0NDX4 |
| K | CRISPR-associated protein, CMR2 family | protein | 1023 | 43% helix, 10% strand | F0NDX2 |
| U | Cognate target RNA | rna | 36 | — | — |
| V | Crrna (48-mer) | rna | 48 | — | — |
| L, M, N, O, P, Q, S, T, W, X, l, m, n, o, p, q, r, s, t, w, x, R | CRISPR-associated protein cmrx | protein | 173 | 11% helix, 27% strand | F0NDX7 |
Ligands and binding sites
- ANP · Phosphoaminophosphonic acid-adenylate ester · ligand · 2 copies · chains K
- MN · Manganese (II) ion · metal · 3 copies · chains K
- ZN · Zinc ion · metal · chains K
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1048 | 0.89 | 0.91 | 121 | empty |
| 2 | 758 | 0.88 | 0.91 | 92 | empty |
| 3 | 1098 | 0.88 | 0.89 | 93 | empty |
| 4 | 1182 | 0.87 | 0.88 | 130 | empty |
| 5 | 846 | 0.85 | 0.87 | 68 | ANP, MN |
Interfaces
99 interfaces between chains.
- H–K · 3110 Ų buried · 39 hydrogen bonds · protein-protein
- I–J · 2093 Ų buried · 21 hydrogen bonds · protein-protein
- D–I · 1769 Ų buried · 16 hydrogen bonds · protein-protein
- F–G · 1716 Ų buried · 22 hydrogen bonds · protein-protein
- H–V · 1632 Ų buried · 34 hydrogen bonds · protein-nucleic
Modifications
Observed in the structure: 15 disulfide (disulfide).
Compared structures
- 6S91 · Cryo-EM structure of the Type III-B Cmr-beta bound to cognate target RNA and AMPPnP… · the same entry in another collection · chain T against T, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt F0NDX5
- Every structure of UniProt F0NDX6
- Every structure of UniProt F0NDX1
- Every structure of UniProt F0NDX3
- Every structure of UniProt F0NDX4
- Every structure of UniProt F0NDX2
- Every structure of UniProt F0NDX7
- Elsewhere: RCSB PDB 6S91 · PDBe 6S91 · UniProt F0NDX5 · UniProt F0NDX6 · UniProt F0NDX1 · UniProt F0NDX3 · UniProt F0NDX4 · UniProt F0NDX2 · UniProt F0NDX7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.